Exclusive: Pfizer negotiating 2-3 percent Allergan break-up fee - sources
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- AMD shares fall amid AI chip sector selloff
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- JetBlue shares fall amid American results, fuel cost concerns
Enanta Pharma (ENTA) Receives $30M Milestone from AbbVie
November 20, 2015 9:06 AM ESTEnanta Pharma (NASDAQ: ENTA) disclosed the following on Friday morning:
Enanta Pharmaceuticals, Inc. has earned a $30 million milestone payment from AbbVie following the recent price reimbursement approval in Japan of AbbVies VIEKIRAX treatment for HCV infection, which had been approved for regulatory... More
New Treasury Guidelines on Inversion May Not Apply to Allergan (AGN)/Pfizer (PFE) - Evercore ISI's Raffat
November 20, 2015 8:33 AM ESTThere's lots of analyst chatter this morning on the pending Allergan (NYSE: AGN), Pfizer (NYSE: PFE) deal amid the... More



